- Home
- VRNT vs COGT Comparison
VRNT vs COGT Comparison
Compare VRNT & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNT
- COGT
- Stock Information
- Founded
- VRNT 1994
- COGT 2014
- Country
- VRNT United States
- COGT United States
- Employees
- VRNT N/A
- COGT N/A
- Industry
- VRNT EDP Services
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- VRNT Technology
- COGT Health Care
- Exchange
- VRNT Nasdaq
- COGT Nasdaq
- Market Cap
- VRNT 1.1B
- COGT 1.1B
- IPO Year
- VRNT N/A
- COGT 2018
- Fundamental
- Price
- VRNT $21.57
- COGT $12.09
- Analyst Decision
- VRNT Buy
- COGT Strong Buy
- Analyst Count
- VRNT 7
- COGT 9
- Target Price
- VRNT $31.71
- COGT $20.25
- AVG Volume (30 Days)
- VRNT 2.2M
- COGT 4.9M
- Earning Date
- VRNT 09-03-2025
- COGT 08-05-2025
- Dividend Yield
- VRNT N/A
- COGT N/A
- EPS Growth
- VRNT 79.53
- COGT N/A
- EPS
- VRNT 0.84
- COGT N/A
- Revenue
- VRNT $896,006,000.00
- COGT N/A
- Revenue This Year
- VRNT $7.73
- COGT N/A
- Revenue Next Year
- VRNT $5.47
- COGT N/A
- P/E Ratio
- VRNT $25.75
- COGT N/A
- Revenue Growth
- VRNT N/A
- COGT N/A
- 52 Week Low
- VRNT $14.15
- COGT $3.72
- 52 Week High
- VRNT $37.31
- COGT $12.97
- Technical
- Relative Strength Index (RSI)
- VRNT 58.67
- COGT 78.94
- Support Level
- VRNT $19.57
- COGT $11.84
- Resistance Level
- VRNT $22.68
- COGT $12.79
- Average True Range (ATR)
- VRNT 0.75
- COGT 0.70
- MACD
- VRNT 0.01
- COGT -0.03
- Stochastic Oscillator
- VRNT 64.31
- COGT 76.34
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.